Skip to main content
SpringerLink
Log in

Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The hypertensive effect of urapidil, a new antihypertensive agent that acts via central and peripheral alpha-adrenoceptors, has been compared with that of metoprolol in 40 patients with mild essential hypertension. Blood pressure was significantly reduced by both drugs, while the heart rate was reduced only after metoprolol. The increases in systolic blood pressure and heart rate caused by three progressive work loads of bicycle exercise were not affected during urapidil, whereas both were reduced by metoprolol. A slight reduction in forced expiratory volume was observed in some patients during treatment with the beta-blocker. There was no case of orthostatic hypotension during urapidil administration, despite its alpha1-blocking action. Side-effects were rare and negligible with both drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Klemm K, Prusse W, Krüger U (1972) Synthese und physikalischemische Eigenschaften des Antihypertensivums Urapidil. Arzneimittelforsch/Drug Res 27: 1859–1897

    Google Scholar 

  2. Schoetensack W, Bischler P, Dittmann EC, Steinijans W (1977) Tierexperimentelle Untersuchungen über den Einfluß des Antihypertensivums Urapidil auf den Kruslang und die Kreislaufregulation. Arzneimittelforsch/Drug Res 27: 1908–1919

    Google Scholar 

  3. Eltze M (1979) Investigations of the mode of action of a new antihypertensive drug, Urapidil, in the isolated rat vas deferens. Eur J Pharmacol 59: 1–9

    Google Scholar 

  4. Kobrin I, Gallo AJ, Pegram BL, Frolich ED (1984) Urapidil in normotensive and spontaneously hypertensive rats: The effects on systemic and regional haemodynamics and cardiac mass. J Hypertens 2: 317–320

    Google Scholar 

  5. Schoetensack W, Bruckschen EG, Zech K (1983) Urapidil. In: Scriabine A (ed) New drug annual: Cardiovascular drugs. Raven Press, New York, pp 19–48

    Google Scholar 

  6. Haerlin R, Bruckshen EG, Henze F (1981) Antihypertensive Therapie mit Ebrantil Retardkapseln. Ergebnisse einer Multicenterstudie. Therapiewoche 31: 7930–7939

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Clinica Medica Generale e Terapia Medica, Università di Milano, Milano, Italy

    G. Leonetti & A. Zanchetti

  2. INRCA, Casatenovo Brianza, Como, Italy

    C. Mazzola & E. Guffanti

  3. Ospedale Civile, Cassano d'Adda, Milano, Italy

    S. Boni & A. Meani

Authors
  1. G. Leonetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Mazzola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Boni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Guffanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Meani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Zanchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leonetti, G., Mazzola, C., Boni, S. et al. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension. Eur J Clin Pharmacol 30, 637–640 (1986). https://doi.org/10.1007/BF00608208

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00608208

Key words

Search

Navigation